Literature DB >> 20477671

Outcome measures in rheumatoid arthritis: the OMERACT process.

Peter Brooks1, Maarten Boers, Lee S Simon, Vibeke Strand, Peter Tugwell.   

Abstract

The development of valid outcome measures is essential for appropriate management of any condition, but particularly chronic rheumatic diseases, such as rheumatoid arthritis. Over the last 15 years, Outcome Measures in Arthritis Clinical Trials has been dedicated to developing such measures in a variety of musculoskeletal conditions, including rheumatoid arthritis, osteoarthritis, osteoporosis, ankylosing spondylitis and gout.

Entities:  

Year:  2007        PMID： 20477671     DOI： 10.1586/1744666X.3.3.271

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


  2 in total

Review 1.  The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.

Authors:  Anna-Maria Hoffmann-Vold; Yannick Allanore; Elisabeth Bendstrup; Cosimo Bruni; Oliver Distler; Toby M Maher; Marlies Wijsenbeek; Michael Kreuter
Journal:  Respir Res       Date:  2020-07-23

2.  Developing Core Outcome Sets (COS) and Core Outcome Measures Sets (COMS) in Cosmetic Gynecological Interventions: Protocol for a Development and Usability Study.

Authors:  Stergios K Doumouchtsis; Vivek Nama; Gabriele Falconi; Maria Patricia Rada; Jittima Manonai; George Iancu; Jorge Milhem Haddad; Cornelia Betschart
Journal:  JMIR Res Protoc       Date:  2021-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.